These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26404779)

  • 1. Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.
    Tzveova R; Naydenova G; Yaneva T; Dimitrov G; Vandeva S; Matrozova Y; Pendicheva-Duhlenska D; Popov I; Beltheva O; Naydenov C; Tarnovska-Kadreva R; Nachev G; Mitev V; Kaneva R
    Biochem Genet; 2015 Dec; 53(11-12):319-33. PubMed ID: 26404779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
    King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
    Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC
    Pharmacogenet Genomics; 2007 May; 17(5):349-58. PubMed ID: 17429317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.
    Haschke-Becher E; Kirchheiner J; Trummer O; Grünbacher G; Kainz A; Boehm BO; März W; Renner W
    Pharmacogenomics; 2010 Oct; 11(10):1359-65. PubMed ID: 21047199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
    Börgel J; Bulut D; Hanefeld C; Neubauer H; Mügge A; Epplen JT; Holland-Letz T; Spiecker M
    BMC Cardiovasc Disord; 2008 Dec; 8():41. PubMed ID: 19105833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage.
    Li Y; You C; Liu Z; He F; Zhao F; Song X; Xie Z; Wei S; Yang Y; Wei H; Che F; Yu J
    J Stroke Cerebrovasc Dis; 2023 Mar; 32(3):106974. PubMed ID: 36587509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
    Polonikov A; Bykanova M; Ponomarenko I; Sirotina S; Bocharova A; Vagaytseva K; Stepanov V; Churnosov M; Bushueva O; Solodilova M; Shvetsov Y; Ivanov V
    Clin Exp Hypertens; 2017; 39(4):306-311. PubMed ID: 28513222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
    Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
    Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
    Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
    Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
    Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
    Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variance in CYP2C8 and increased risk of myocardial infarction.
    Rodenburg EM; Visser LE; Danser AH; Hofman A; van Noord C; Witteman JC; Uitterlinden AG; Stricker BH
    Pharmacogenet Genomics; 2010 Jul; 20(7):426-34. PubMed ID: 20436375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
    Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population.
    Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Ivakin VE; Katargina LN; Kolesnikova OE
    Dis Markers; 2008; 24(2):119-26. PubMed ID: 18219097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
    Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk.
    Polonikov AV; Ponomarenko IV; Bykanova MA; Sirotina SS; Bocharova AV; Vagaytseva KV; Stepanov VA; Azarova IE; Churnosov MI; Solodilova MA
    Hypertens Res; 2019 Feb; 42(2):257-272. PubMed ID: 30518987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
    Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
    Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China.
    Zhu Q; Fu Z; Ma Y; Yang H; Huang D; Xie X; Liu F; Zheng Y; Cha E
    Clin Biochem; 2013 Aug; 46(12):1047-1054. PubMed ID: 23684773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension.
    Wu SN; Zhang Y; Gardner CO; Chen Q; Li Y; Wang GL; Gao PJ; Zhu DL
    Ann Hum Genet; 2007 Jul; 71(Pt 4):519-25. PubMed ID: 17286575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
    Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
    Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.